Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Genentech"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Genentech."

12 result(s) displayed (1 - 12 of 17)


Survivor, biotech

For every Genentech or Amgen, there's a host of research-based companies that have struggled to get by. Here's the story of how three biotechs kept themselves going when times got tough. Continue reading

Posted on April 25, 2011 12:45 PM




Bayside landing

Susan Desmond-Hellmann, Genentech's former chief of product development since 2004, takes over the chancellor's chair at the University of California, San Francisco. Continue reading

Posted on June 19, 2009 11:51 AM




Antitrust 2.0

The return of tech dealmaking brings with it a revived threat of scrutiny. Continue reading

Posted on June 5, 2009 11:58 AM




Nothing ventured

Why a revitalized venture capital industry is essential to economic recovery. Continue reading

Posted on May 15, 2009 11:51 AM




Little pharma blues

As the economy foundered, drug industry insiders looked forward to an M&A frenzy. But with a few exceptions, deals occurred only at the top of the food chain. Continue reading

Posted on March 20, 2009 1:48 PM




Merck, Schering play follow the pharma

Damian Ridealgh and other Fried Frank attorneys advised Merck on its deal for Schering. Continue reading

Posted on March 20, 2009 1:44 PM




The big trial

From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next? Continue reading

Posted on March 6, 2009 11:29 AM




Risk Arbitrage: March 9, 2009

March 9, 12 and 20 are important days in the M&A world. Continue reading

Posted on March 6, 2009 11:04 AM




Davis Polk, Roche probe Genentech's DNA

Roche and Genentech have a long history. This time around, Davis Polk's John Butler and others take the lead for Roche. Continue reading

Posted on February 20, 2009 3:10 PM




Surprise!

For sheer drama, Roche's hostile, discounted bid for Genentech tops even Pfizer's bid for Wyeth. Continue reading

Posted on February 6, 2009 1:28 PM




Mood enhancers

Drug companies get a warm reception in the debt market these days. Continue reading

Posted on February 6, 2009 1:12 PM




Risk Arbitrage: Feb. 9, 2009

2009 has begun better than it might have on the M&A front. Continue reading

Posted on February 6, 2009 1:00 PM




1 2 Next

Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Real estate investment manager Clarion Partners LLC hired Kerrisha Jenkins as a vice president in Los Angeles. For other updates launch today's Movers & shakers slideshow.

Video

A fast start toward an uncertain finish

Prime Minister Shinzo Abe and Sony CEO Kazuo Hirai are changing Japan. Third Point's Dan Loeb is trying to quicken the pace. More video

Sectors